University Hospital Basel
Basel, 4031, Switzerland
Location contact
Edin Mujagic, Prof. Dr. med.
PRINCIPAL_INVESTIGATOR
Matteo Giardini, Dr. med.
CONTACT
Matteo Giardini, Dr. med.
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07499206
This study aims to assess a simple intervention: Visualization of lymphatic injury + treatment (in case of detection). This will generate data on the incidence of intraoperative lymphatic injury and the effect of treatment. This data will then hopefully enable a multi-center RCT to generate high level evidence on this matter.
Trial opening soon.
Get Notified18 year–100 year
All sexes
Interventional
Not applicable
Basel, 4031, Switzerland
Edin Mujagic, Prof. Dr. med.
PRINCIPAL_INVESTIGATOR
Matteo Giardini, Dr. med.
CONTACT
Matteo Giardini, Dr. med.
PRINCIPAL_INVESTIGATOR
Gaining arterial access in the groin is a very common surgical procedure for vascular surgeons. To reach the femoral artery, invisible lymphatic vessels are often harmed and in turn lymphatic injuries are created. Due to their transparent color and small size, these injuries remain unseen during surgery and are therefore untreated. These small lymphatic injuries can lead to wound complications including lymphoceles, lymphatic fistulas and surgical site infections (SSI) that are associated with higher morbidity and prolonged hospital stay, even mandating re-interventions in some cases.
The investigators hope to reduce wound complication rates by visualizing and directly treating these lymphatic injuries. To be able to detect the injuries, PatentBlau V (E131) will be applied, a blue dye with Swissmedic approval for visualization of lymphatic vessels. Sex differences will be noted and analyzed, gender as a dimension is not relevant.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
PatentBlau V application: 2ml will be injected intradermally around the groin wound. After allowing a maximum of 10 minutes for lymphatic uptake of the blue dye, a thorough inspection of the wound will be performed to detect possible lymphatic injuries, which will be visible by the blue color.
Direct treatment (e.g. suture, clipping) of visible lymphatic injuries will be performed.
Time frame: Up to 30 days postoperatively
Wound complications defined as follows:
Lymphocele: localized fluid collection at the site of surgical dissection; Lymphatic fistula: persistent external drainage of clear fluid for the wound > 72h after surgery; Surgical Site Infection (SSI): according to the CDC definitions.
Time frame: Intraoperatively
Time frame: Up to 30 days postoperatively
Time frame: Up to 30 days postoperatively
Time frame: Up to 30 days postoperatively
Contact information is provided by the study sponsor or research team.
University Hospital, Basel, Switzerland
Other
Visualization and Treatment of Lymphatic Injury During Vascular Surgery Procedures in the Groin: A Pilot Study
Acronym: LymphFistula-P
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04894864
Abdominal Aortic Aneurysm Without Rupture, Anesthesia
Heraklion, Crete, Greece
View Trial DetailsNCT04014647
Vascular Surgical Procedure
Norwich, Norfolk, United Kingdom
View Trial DetailsNCT07164040
Brain Diseases, Cardiovascular Diseases
Porto, Portugal
View Trial DetailsNCT06456125
Aneurysm, Aneurysm, False
Valencia, Spain
View Trial Details